Kingsman Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4M Buy
2,833
+923
+48% +$943K 1.59% 17
2026
Q1
$1.76M Buy
1,910
+130
+7% +$132K 0.99% 24
2025
Q4
$1.91M Buy
1,780
+1,243
+231% +$1.19M 1.03% 20
2025
Q3
$410K Sell
537
-879
-62% -$654K 0.23% 49
2025
Q2
$1.1M Sell
1,416
-645
-31% -$501K 0.69% 23
2025
Q1
$1.7M Buy
+2,061
New +$1.71M 1.24% 19

Other funds holding LLY

Kingsman Wealth Management's LLY Position: Q2 2026 in Review

Kingsman Wealth Management increased its Eli Lilly (LLY) stake by 48% in Q2 2026, buying an estimated $943K and bringing the position to 2,833 shares worth $3.4M. The position accounts for 1.59% of the portfolio, ranked #17.

Kingsman Wealth Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,553 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kingsman Wealth Management held 2,833 shares of Eli Lilly worth $3.4M as of Q2 2026.
  • Kingsman Wealth Management bought 923 Eli Lilly shares in Q2 2026, an estimated $943K.
  • Eli Lilly made up 1.59% of Kingsman Wealth Management's portfolio in Q2 2026, its #17 holding.
  • Kingsman Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,553 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kingsman Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.